The vision for this new company came to be when Tyson was introduced to Chad Bronstein while working as an advisor and investor in Wesana Health. Wesana is a biotech company that centers around the development of psilocybin into an effective treatment to manage traumatic brain injuries. Chad Bronstein is the co-founder and executive chairman of Wesana Health and he is also the CEO of the cannabis tech firm Fyllo. It came as no surprise when it was announced that he will also serve as the Chairman of Tyson 2.0.